CNMD CONMED Earnings and EPS analysis

EPS in 2026 (TTM): $2.42

Last Report Period Date: Sep 30, 2026

Currently, CNMD's trailing twelve months (TTM) EPS stands at $2.42, according to the most recent financial reports. In 2025, CNMD reported a per-share earnings of $1.52, which represents a decrease compared to the EPS of $4.29 recorded in 2024. CNMD recorded an EPS of $0.66 for the quarterly period ending on Sep 30, 2026.

In 2025, CONMED's EPS was $1.52, a decrease of 64.6% from $4.29 in 2024. For the quarter ending Sep 30, 2026, the EPS was $0.66, reflecting a 633.3% increase compared to the same quarter a year earlier. The trailing twelve months (TTM) EPS as of September 2026 is $2.42. In 2024, the annual EPS was $4.29, showing an increase of 104.3% compared to 2023.

CONMED has recorded a growth in earnings per share of 633.3% over the past 12 months (YoY, quarterly). CONMED had an average annual EPS growth of 35.7% over the last five years. Over the last decade, CNMD had an average annual earnings per share growth of 3.3%.